Travere Therapeutics Ownership | Who Owns Travere Therapeutics?
Travere Therapeutics Ownership Summary
Travere Therapeutics is owned by 37.26% institutional investors, 0.76% insiders, and 61.98% retail investors. Blackrock is the largest institutional shareholder, holding 9.86% of TVTX shares. Delaware Small Cap Core I is the top mutual fund, with 4.42% of its assets in Travere Therapeutics shares.
TVTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Travere Therapeutics | 37.26% | 0.76% | 61.98% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 7.64M | 9.86% | $62.84M |
| Blackrock funding, inc. /de | 7.87M | 8.82% | $300.69M |
| Armistice capital | 6.72M | 7.56% | $160.70M |
| Vanguard group | 6.31M | 7.07% | $241.08M |
| Janus henderson group | 4.06M | 5.22% | $70.69M |
| Perceptive advisors | 3.79M | 4.27% | $90.69M |
| Adage capital partners gp | 3.55M | 3.99% | $84.89M |
| State street | 3.22M | 3.62% | $76.91M |
| Fmr | 2.89M | 3.25% | $69.17M |
| D. e. shaw | 2.28M | 2.93% | $39.69M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Knott david m jr | 186.00K | 3.29% | $7.11M |
| Rock springs capital management lp | 2.16M | 3.02% | $51.74M |
| Perceptive advisors | 3.79M | 2.62% | $90.69M |
| Armistice capital | 6.72M | 2.38% | $160.70M |
| Eversept partners, lp | 1.42M | 2.33% | $33.87M |
| Exome asset management | 156.92K | 2.27% | $3.75M |
| Palisades investment partners | 137.77K | 1.99% | $5.26M |
| Emerald advisers | 1.59M | 1.88% | $60.91M |
| Emerald mutual fund advisers trust | 948.46K | 1.77% | $36.24M |
| Kynam capital management, lp | 949.73K | 1.69% | $22.70M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 4.06M | 0.04% | 4.03M |
| Perceptive advisors | 3.79M | 2.62% | 2.96M |
| Fmr | 2.89M | 0.00% | 1.83M |
| Wellington management group llp | 1.20M | 0.01% | 1.17M |
| Fiera capital | 874.05K | 0.11% | 874.05K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Macquarie group | - | - | -4.98M |
| Viking global investors lp | - | - | -2.60M |
| Armistice capital | 6.72M | 2.38% | -2.15M |
| Finepoint capital lp | - | - | -1.78M |
| Logos global management lp | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Fiera capital | 874.05K | 0.11% | 874.05K | $33.40M |
| Jane street group | 392.27K | 0.00% | 392.27K | $14.99M |
| Arrowstreet capital, limited partnership | 328.65K | 0.01% | 328.65K | $7.85M |
| Jump financial | 315.03K | 0.09% | 315.03K | $7.53M |
| Neuberger berman group | 211.67K | 0.00% | 211.67K | $5.06M |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -1.00 |
| Wealthspire advisors | -4.00 |
| Nelson, van denburg & campbell wealth management group | -14.00 |
| American national bank | -15.00 |
| Whittier trust | -16.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 123 | -52.69% | 33,249,544 | -66.99% | 37 | 0.29% | 78 | -43.48% | 36 | -52.00% |
| Sep 30, 2025 | 97 | -54.46% | 31,195,759 | -67.08% | 35 | 0.31% | 55 | -52.17% | 27 | -59.09% |
| Jun 30, 2025 | 221 | -4.74% | 100,360,560 | 2.40% | 112 | 0.92% | 115 | -13.53% | 71 | 20.34% |
| Mar 31, 2025 | 11 | -94.74% | 4,535,953 | -95.23% | 5 | 0.03% | 5 | -96.12% | 3 | -94.12% |
| Dec 31, 2024 | 107 | -42.47% | 35,070,340 | -57.58% | 45 | 0.40% | 66 | -30.53% | 23 | -58.93% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Delaware Small Cap Core I | 3.45M | 4.42% | -21.39K |
| Macquarie Small Cap Core I | 3.36M | 3.77% | -252.48K |
| State Street® SPDR® S&P® Biotech ETF | 2.92M | 3.16% | -15.61K |
| Vanguard Total Stock Mkt Idx Inv | 2.82M | 3.06% | 8.01K |
| Aviva Investors GlConvtAbsRet I USD Acc | 2.20M | 2.88% | -229.35K |
| Vanguard US Total Market Shares ETF | 2.51M | 2.82% | - |
| Strategic Advisers Fidelity US TtlStk | 2.50M | 2.71% | 1.92M |
| Nomura Small Cap Core I | 2.44M | 2.65% | -711.88K |
| iShares Russell 2000 ETF | 1.99M | 2.16% | 673.75K |
| SPDR® S&P Biotech ETF | 1.51M | 1.69% | 3.37K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | $1.81M |
| Feb 17, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | Sell | $122.12K |
| Feb 17, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | Sell | $156.20K |
| Feb 04, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | $7.62K |
| Feb 04, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | $49.67K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 21 |
| 2025 Q4 | - | 12 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 6 |
| 2025 Q1 | - | 26 |
TVTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools